InvestorsHub Logo
Followers 4
Posts 172
Boards Moderated 0
Alias Born 03/02/2015

Re: None

Monday, 07/11/2022 5:50:30 PM

Monday, July 11, 2022 5:50:30 PM

Post# of 1043
OTLK - CORPORATE PRESENTATIONS JULY 05, 2022
Good News:

U.S. FDA BLA submission targeted September 2022 with anticipated approval to follow 8-12 months later.
Sufficient capital for pre-launch activities and potentially through launch.
SOURCE:

https://ir.outlooktherapeutics.com/static-files/65b18fdb-77dd-4afb-8401-1169d0f9a743
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent OTLK News